Ahead of the second reading of the Border Security, Asylum and Immigration Bill today, Médecins Sans Frontières / Doctors ...

Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine. New Drug Application (NDA) Submission Expected in the ...

A look at the nine reports the Jacksonville Office of Inspector General issued in 2024 and the two so far this year.

Grace Therapeutics intends to use the upfront net proceeds from the private placement for general corporate purposes and to fund pre-commercial development of GTx-104, a clinical stage, novel, ...

Pliant Therapeutics has pumped the breaks on a mid-stage trial of its lead liver disease drug on the advice of its safety ...

Recent federal developments may soon require cosmetic companies to adopt stringent precautions to ensure that talc-containing ...

On February 6, 2025, the SEC announced that it was providing a temporary exemption from compliance with Rule 13f-2 under the ...